OMEPRAZOLE PROVIDES FASTER HEALING AND SYMPTOM RELIEF OF REFLUX ESOPHAGITIS THAN CIMETIDINE

被引：0
|
作者：
BATE, CM
KEELING, PWN
OMORAIN, CA
WILKINSON, SP
MOUNTFORD, RA
TEMPERLEY, JM
FOSTER, DN
HARVEY, RF
THOMPSON, DG
FORGACS, IC
BASSETT, KS
RICHARDSON, PDI
机构：
[1] GASTROENTEROL UNIT, WIGAN, ENGLAND
[2] GASTROENTEROL UNIT, DUBLIN, IRELAND
[3] GASTROENTEROL UNIT, GLOUCESTER, ENGLAND
[4] GASTROENTEROL UNIT, BRISTOL, ENGLAND
[5] GASTROENTEROL UNIT, PRESTON, ENGLAND
[6] GASTROENTEROL UNIT, ROCHDALE, ENGLAND
[7] GASTROENTEROL UNIT, SALFORD, ENGLAND
[8] GASTROENTEROL UNIT, DULWICH, ENGLAND
[9] ASTRA PHARMACEUT LTD, LONDON, ENGLAND
来源：
GUT | 1989年 / 30卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1493 / A1494
页数：2
相关论文
共 50 条
  • [41] Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis
    Bate, CM
    Green, JRB
    Axon, ATR
    Murray, FE
    Tildesley, G
    Emmas, CE
    Taylor, MD
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (04) : 755 - 763
  • [42] Lansoprazole provides greater symptom relief than ranitidine in acid-related dyspepsia
    Jones, RH
    Lewis, GL
    GASTROENTEROLOGY, 1996, 110 (04) : A145 - A145
  • [43] Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial
    Kahrilas, PJ
    Falk, GW
    Johnson, DA
    Schmitt, C
    Collins, DW
    Whipple, J
    D'Amico, D
    Hamelin, B
    Joelsson, B
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (10) : 1249 - 1258
  • [44] Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis
    Hatlebakk, JG
    Berstad, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) : 365 - 372
  • [45] HYDROXYPROLINE IN THE ESOPHAGEAL MUCOSA OF PATIENTS WITH PROGRESSIVE SYSTEMIC-SCLEROSIS DURING OMEPRAZOLE-INDUCED HEALING OF REFLUX ESOPHAGITIS
    HENDEL, L
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1991, 5 (05) : 471 - 480
  • [46] Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment
    Annibale, B
    Franceschi, M
    Fusillo, M
    Beni, M
    Cesana, B
    Delle Fave, G
    HEPATO-GASTROENTEROLOGY, 1998, 45 (21) : 742 - 751
  • [47] Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
    Chiba, N
    DeGara, CJ
    Wilkinson, JM
    Hunt, RH
    GASTROENTEROLOGY, 1997, 112 (06) : 1798 - 1810
  • [48] Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment
    Bytzer, Peter
    Morocutti, Anna
    Kennerly, Peter
    Ravic, Miroslav
    Miller, Neil
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (10) : 1132 - 1140
  • [49] Superiority of 20mg pantoprazole (PANTO) vs 150mg x 2 ranitidine (RANI) in healing and symptom relief of patients with mild reflux esophagitis.
    Ramirez-Barba, EJ
    Di Silvio, M
    Dibildox, M
    Moguel, A
    Rodriguez, F
    Almaguer, I
    Andrade, P
    Fischer, R
    Klein, M
    Wurst, W
    GASTROENTEROLOGY, 1998, 114 (04) : A264 - A264
  • [50] Is surgery more effective than medical therapy for long-term symptom control in patients with reflux esophagitis?
    Boyer, Jean
    O'Toole, Dermot
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (10): : 544 - +
12345